Search results
Results From The WOW.Com Content Network
Leprosy has historically been associated with social stigma, which continues to be a barrier to self-reporting and early treatment. [4] Leprosy is classified as a neglected tropical disease. [21] World Leprosy Day was started in 1954 to draw awareness to those affected by leprosy. [22] [4] The study of leprosy and its treatment is known as ...
Leprosy, one of the world’s oldest and most persistent diseases, may have the surprising ability to grow and regenerate livers, new research has suggested. ... To overcome these harmful side ...
Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum (ENL). (From AMA Drug Evaluations Annual, 1993, p1619). The drug is given as an alternative to people who can not tolerate the effects of dapsone for leprosy. [8]
A new CDC report suggests cases are rising in some states. Here's what you need to know about the condition.
Overall, the risk of getting leprosy for any adult around the world is very low. That’s because more than 95% of all people have natural immunity to the disease.
Mycobacterium leprae (also known as the leprosy bacillus or Hansen's bacillus) is one [a] of the two species of bacteria that cause Hansen's disease (leprosy), [1] a chronic but curable infectious disease that damages the peripheral nerves and targets the skin, eyes, nose, and muscles.
Leprosy is typically treated with a combination of antibiotics and treatment usually lasts one to two years, per the CDC. “It is a very slowly multiplying bacteria in the body, so you have to ...
Clofazimine is given to treat sulfone-resistant leprosy or to patients who are intolerant to sulfones. It also exerts an antiinflammatory effect and prevents erythema nodosum leprosum, which can interrupt treatment with dapsone. This is a major advantage of clofazimine over other antileprosy drugs.